×
Home Current Archive Editorial board
News Contact
Review paper

Lifestyle risk factors and comorbidities of cancer patients in a country with limited resources

By
Nejra Mlačo Orcid logo ,
Nejra Mlačo
Contact Nejra Mlačo

School of Medicine, University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Armin Šljivo ,
Armin Šljivo

School of Medicine, University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Ahmed Mulać ,
Ahmed Mulać

School of Medicine, University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Amina Kurtović-Kozarić ,
Amina Kurtović-Kozarić

Department of Clinical Pathology, Cytology and Human Genetics, Clinical Centre of the University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Anes Pašić ,
Anes Pašić

Clinic of Oncology, Clinical Centre of the University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Semir Bešlija ,
Semir Bešlija

Clinic of Oncology, Clinic of Oncology, Clinical Centre of the University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Šejla Cerić ,
Šejla Cerić

Clinic of Nuclear Medicine and Endocrinology, Clinical Centre of the University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Timur Cerić
Timur Cerić
Contact Timur Cerić

Clinic of Oncology, Clinical Centre of the University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Abstract

Aim
To investigate quality of life and exposure to lifestyle risk factors of cancer patients in Bosnia and Herzegovina and a correlation of cancer type with lifestyle risk factors.
Methods
This was a cross-sectional study conducted on 200 cancer patients from the Clinical Centre of the University of Sarajevo. The respondents completed an anonymous questionnaire consisting of seven sections: basic patient information, physical activity, dietary habits including alternative medicine, tobacco use, alcohol consumption, anxiety, and comorbidities.
Results
A total of 150 (75%) patients were overweight with 113 (56%) of them being less physically active after the confirmed diagnosis. After the diagnosis, 79 (40%) patients ate less food, and 154 (77%) healthier; 130 (65%) reported consumption of alternative medicine and food supplements, 39 (30%) spent >1/4 of average monthly salary on these products. Majority never consumed alcohol, 135 (68%) and 101 (51%) patients reported history of tobacco use. Being obese was an independent predictor for colorectal carcinoma; being less obese was linked to a decreased risk of breast cancer diagnosis. Physical activity was linked to a decreased risk of lung cancer diagnosis. Many patients (122; 61%) reported having chronic comorbidities, mostly hypertension, while 44 (22%) patients were proven to be clinically anxious.
Conclusion
Our data suggest lack of public awareness of the consequences of unhealthy lifestyles. Risk factors such as alcohol consumption and tobacco use differed from other European countries. Significance of lifestyle changes after the diagnosis for reducing mortality and cancer recurrence requires further research. Prevention programs and more data are needed.

References

1.
Anand P, Kunnumakkara A, Kunnumakara A, Sundaram C, Harikumar K, Tharakan S, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008;2097–116.
2.
Global Cancer Observatory. 2018;
3.
Berger N. Obesity and cancer pathogenesis. Ann N Y Acad Sci. 2014;57–76.
4.
Allott E, Masko E, Freedland S. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013;800–9.
5.
Haehling V, Anker S, S. Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle. 2010;1–5.
6.
Schulz K, Patra S, Spielmann H, Klapdor S, Schlüter K, Eckert V, et al. Physical condition, nutritional status, fatigue, and quality of life in oncological out-patients. SAGE Open Med. 2017;2050312117743674.
7.
Ligibel J. Lifestyle factors in cancer survivorship. J Clin Oncol. 2012;3697–704.
8.
Peters R, Ee N, Peters J, Beckett N, Booth A, Rockwood K, et al. Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction. Ther Adv Chronic Dis. 2019;2040622319880392.
9.
Centers for Disease Control and Prevention (US). 2014;
10.
Warren G, Alberg A. Smoking cessation after cancer diagnosis and survival in cancer patients. J Clin Oncol. 2018;1561.
11.
Seitz H, Becker P. Alcohol metabolism and cancer risk. Alcohol Res Health. 2007;44–7.
12.
Schwedhelm C, Boeing H, Hoffmann G, Aleksandrova K, Schwingshackl L. Effect of diet on mortality and cancer recurrence among cancer survivors: a systematic review and meta-analysis of cohort studies. Nutr Rev. 2016;737–48.
13.
Holland J, Andersen B, Breitbart W, Buchmann L, Compas B, Deshields T, et al. Distress Management: Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2013;190–209.
14.
Youth F, Stoto M, Almario D, Mccormick M. Reducing the Odds: Preventing Perinatal Transmission of HIV In The United States. Public Health Screening Programs. 1999;(2).
15.
Salibasic M, Delibegovic S. The Quality of Life and Degree of Depression of Patients Suffering from Breast Cancer. Med Arch. 2018;202–5.
16.
Trninić Z, Vidacak A, Vrhovac J, Petrov B, Setka V. Quality of life after colorectal cancer surgery in patients from University Clinical Hospital Mostar, Bosnia and Herzegovina. Coll Antropol. 2009;(Suppl 2):1–5.
17.
Glavić Z, Galić S, Krip M. Quality of life and personality traits in patients with colorectal cancer. Psychiatr Danub. 2014;172–80.
18.
Dunstan D, Scott N. Assigning Clinical Significance and Symptom Severity Using the Zung Scales: Levels of Misclassification Arising from Confusion between Index and Raw Scores. Depress Res Treat. 2018;9250972.
19.
WHO Global Health Observatory. Data Repository. 2013;
20.
Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin J, Friedman E, Slingerland J. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;378–97.
21.
Cancer country profiles. 2014;
22.
Holmes M, Chen W, Feskanich D, Kroenke C, Colditz G. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;2479–86.
23.
Mitchell A, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a metaanalysis of 94 interview-based studies. Lancet Oncol. 2011;160–74.
24.
Patel A, Carter B, Stevens V, Gaudet M, Campbell P, Gapstur S. The relationship between physical activity, obesity, and lung cancer risk by smoking status in a large prospective cohort of US adults. Cancer Causes Control. 2017;1357–68.
25.
Zhang X, Liu Y, Shao H, Zheng X. Obesity Paradox in Lung Cancer Prognosis: Evolving Biological Insights and Clinical Implications. J Thor Oncol. 2017;1478–88.
26.
Audrain-Mcgovern J, Benowitz N. Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther. 2011;164–8.
27.
Gavazzi C, Sieri S, Traclò F, Sproviero A, Vandoni G, Ricci R, et al. Changes in food habits in cancer patients in Italy: a survey. AIOM-SINPE-FAVO. Nutrition. 2018;140–5.
28.
Salminen E, Lagström H, Heikkilä S, Salminen S. Does breast cancer change patients’ dietary habits? Eur J Clin Nutr. 2000;844–8.
29.
Levi F. Cancer prevention: epidemiology and perspectives. Eur J Cancer. 1999;1046–58.
30.
Meat, fish and dairy products and the risk of cancer. World Cancer Research Fund. 2018;
31.
Tseng T, Lin H, Moody-Thomas S, Martin M, Chen T. Who tended to continue smoking after cancer diagnosis: the national health and nutrition examination survey 1999-2008. BMC Public Health. 2012;784.
32.
Warren G, Marshall J, Cummings K, Toll B, Gritz E, Hutson A, et al. Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. 2013;258–62.
33.
Corrao G, Bagnardi V, Zambon A, Arico S. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction. 1999;1551–73.
34.
Liu Y, Nguyen N, Colditz G. Links between alcohol consumption and breast cancer: a look at the evidence. Womens Health (Lond). 2015;65–77.
35.
Saquib J, Madlensky L, Kealey S, Saquib N, Natarajan L, Newman V, et al. Classification of CAM use and its correlates in patients with early-stage breast cancer. Integr CancerTher. 2011;138–47.
36.
Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;343–51.
37.
Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;337–50.
38.
Federation of Bosnia and Herzegovina. Strategija za prevenciju, tretman i kontrolu malignih neoplazmi u Federaciji Bosne i Hercegovine 2012-2020 (Strategies for prevention, treatment and control of malignant neoplasms in Federation of Bosnia and Herzegovina). 28AD;

Citation

Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.